TCIM
NVIV

TIAA CREF Investment Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

TIAA CREF Investment Management’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5
Closed -$364K – 3223
2017
Q1 		$364K Hold
5
– – ﹤0.01% 2890
2016
Q4 		$391K Hold
5
– – ﹤0.01% 2918
2016
Q3 		$691 Hold
5
– – ﹤0.01% 2726
2016
Q2 		$590K Hold
5
– – ﹤0.01% 2790
2016
Q1 		$608K Hold
5
– – ﹤0.01% 2727
2015
Q4 		$627K Sell
5
-2
-29% -$297K ﹤0.01% 2817
2015
Q3 		$1.12M Buy
7
+2
+40% +$467K ﹤0.01% 2505
2015
Q2 		$1.4M Buy
+5
New +$1.32M ﹤0.01% 2507

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIAA CREF Investment Management's NVIV Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2017, closing a stake of 5 shares — an estimated $364K sold.

TIAA CREF Investment Management first reported a position in NVIV in Q2 2015 and held it in 8 quarters. The position peaked at $1.4M in Q2 2015. 37 funds tracked by Wall St. Rank hold NVIV as of Q2 2017.

  • TIAA CREF Investment Management reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 5 InVivo Therapeutics Holdings Corp shares in Q2 2017, an estimated $364K.
  • TIAA CREF Investment Management first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 8 quarters.
  • TIAA CREF Investment Management's InVivo Therapeutics Holdings Corp position peaked at $1.4M in Q2 2015.
  • 37 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.